BioHarvest Sciences Inc. (CSE:BHSC, NASDAQ:BHST) announced it has partnered with Tate & Lyle PLC (LSE:TATE) to develop proprietary plant-based molecules for food and beverage ingredients.
The partnership will focus on developing botanical sweeteners that aim to provide a sugar-like taste without an aftertaste.
BioHarvest’s Botanical Synthesis platform grows targeted plant cells to replicate and enhance phytonutrients without cultivating entire plants, producing non-GMO, plant-derived ingredients in a more sustainable way.
Tate & Lyle will contribute expertise in sugar reduction, ingredient research, and access to global customers as part of its open innovation program, the company highlighted.
"We aspire to improve human wellness by availing our plant-derived molecules to hundreds of millions of people and Tate & Lyle represents an ideal partner,” BioHarvest Sciences CEO Ilan Sobel said in a statement.
“Tate & Lyle is a global powerhouse in food ingredient innovation, and we expect that its regulatory and nutrition expertise, industry knowledge and complementary research initiatives will help expedite and commercialise the next generation of plant-based molecules developed through our Botanical Synthesis platform."
Nick Hampton, Tate & Lyle CEO added that this partnership with BioHarvest will allow the company to provide its customers with the latest innovation in the marketplace.
“Our open innovation programme is all about creating cutting-edge solutions for the food and beverage industry. By partnering with entrepreneurial innovators like BioHarvest, we aim to disrupt the future of food for the better,” Hampton said.